Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Atlantic's 2-5A antisense compound shows excellent anti-RSV activity in vitro

April 21, 1998

New antiparasitic compounds from Kitasato Institute

April 21, 1998

ViroPharma's new antiinfluenza agents

April 17, 1998

New anti-HSV agents synthesized in Taiwan

April 16, 1998

Pentose begins phase I/II trials of PEN-203

April 16, 1998

Beta-lactamase inhibitors available for licensing from RCT

April 16, 1998

Antiviral drugs advisory committee will discuss Priftin NDA

April 15, 1998

Erythromycins for Gram-positive and other infections in development at HMR

April 14, 1998

Famciclovir shows better activity than valaciclovir in preclinical trials for the treatment of HSV

April 14, 1998

IntraBiotics develops novel cyclic peptide antimicrobials

April 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...